Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07788833 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial
NCT07788833 · ClinicalTrials.gov record · last posted 2026-08-27

A Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety and Efficacy of RSB11-HI Postbiotic Supplementation for Supporting Weight Management, Metabolic Wellness, and Quality of Life in Healthy Adults

StatusRecruiting
PhaseNot applicable
Started2026-08
View on ClinicalTrials.gov ↗
from the ClinicalTrials.gov record
This randomized, double-blind, placebo-controlled clinical trial will evaluate the safety, tolerability, and efficacy of RSB11-HI, a heat-inactivated postbiotic, in healthy adults over an 8-week intervention period. Participants will be classified into one of three predefined study populations-General Healthy, Perimenopausal, or Mild Inflammation-and will then be randomized within their assigned population to receive either RSB11-HI or placebo. The study will evaluate the effects of supplementation on healthy weight management, metabolic wellness, gastrointestinal health, and quality of life, while also exploring whether responses differ among the predefined study populations.
Trial Details
NCT Number NCT07788833
Lead Sponsor Able Biolabs, LLC
Conditions Healthy Weight Management, Metabolic Wellness, Gastrointestinal Health, Quality of Life
Enrollment 120 participants
Start Date 2026-08
Primary Completion 2026-11 (estimated)
Study Completion 2026-11 (estimated)
Updated on ClinicalTrials.gov 2026-08-27